Magle PharmaCept Expands Distribution Agreement to Include Strategic European Territories

01/07/2024

Magle PharmaCept, a subsidiary of Magle Group, is pleased to announce the extension of its distribution agreement with its key distributor in the wound care field. The expanded agreement now includes strategic European territories, enhancing our reach and reinforcing our commitment to providing innovative wound care solutions across the region.

AXXO® Woundgel, the brand owned by our distributor AXXO, is at the forefront of this initiative. This advanced wound care product utilizes our proprietary DSM (Degradable Starch Microspheres) technology to offer effective treatment for various types of wounds. The gel provides a moist environment that promotes healing, reduces pain, and minimizes the risk of infection.

Check out the press release & Read more!